|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Laboratory for Molecular Stem Cell Biology, Center for Biomedical Research and Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany;
Institute for Neurophysiology, University of Cologne, Cologne, Germany; and
Department of Hematology and Oncology, University Hospital, Frankfurt/Main, Germany
The BCR-ABL1 kinase expressed in acute lymphoblastic leukemia (ALL) drives malignant transformation of pre-B cells and prevents further development. We studied whether inhibition of BCR-ABL1 kinase activity using STI571 can relieve this differentiation block. STI571 treatment of leukemia patients induced expression of the Ig L chain-associated transcription factors IRF4 and SPIB, up-regulation of RAG1 and RAG2, C
and C
germline transcription, and rearrangement of Ig
L chain (IGK) and Ig
L chain (IGL) genes. However, STI571-treated pre-B ALL cells expressed
L, but almost no
L chains. This could be explained by STI571-induced rearrangement of the
-deleting element (KDE), which can delete productively rearranged V
-J
joints. Amplifying double-strand breaks at recombination signal sequences within the IGK, KDE, and IGL loci revealed a coordinated sequence of rearrangement events induced by STI571: recombination of IGK gene segments was already initiated within 1 h after STI571 treatment, followed by KDE-mediated deletion of V
-J
joints 6 h later and, ultimately, IGL gene rearrangement after 12 h. Consistently, up-regulation of C
and C
germline transcripts, indicating opening of IGK and IGL loci, was detected after 1 and 6 h for IGK and IGL, respectively. Continued activity of the recombination machinery induced secondary IGK gene rearrangements, which shifted preferential usage of upstream located J
- to downstream J
-gene segments. Thus, inhibition of BCR-ABL1 in pre-B ALL cells 1) recapitulates early B cell development, 2) directly shows that IGK, KDE, and IGL genes are rearranged in sequential order, and 3) provides a model for Ig L chain gene regulation in the human.
This article has been cited by other articles:
![]() |
W. Su, J. N. Gordon, F. Barone, L. Boursier, W. Turnbull, S. Mendis, D. K. Dunn-Walters, and J. Spencer Lambda Light Chain Revision in the Human Intestinal IgA Response J. Immunol., July 15, 2008; 181(2): 1264 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hsu and M. F. Criscitiello Diverse Immunoglobulin Light Chain Organizations in Fish Retain Potential to Revise B Cell Receptor Specificities J. Immunol., August 15, 2006; 177(4): 2452 - 2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Feldhahn, P. Rio, B. N. B. Soh, S. Liedtke, M. Sprangers, F. Klein, P. Wernet, H. Jumaa, W.-K. Hofmann, H. Hanenberg, et al. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells PNAS, September 13, 2005; 102(37): 13266 - 13271. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |